The remarkable conformational plasticity of alpha-synuclein: blessing or curse?
- PMID: 23648364
- DOI: 10.1016/j.molmed.2013.04.002
The remarkable conformational plasticity of alpha-synuclein: blessing or curse?
Abstract
The aggregation of the protein alpha-synuclein (α-SYN) is believed to be a critical event in Parkinson's disease (PD). α-SYN is characterized by a remarkable conformational plasticity, adopting different conformations depending on the environment. In vitro, α-SYN lacks a well-defined structure. Therefore, it was classified as an 'intrinsically disordered protein'. A debate has recently begun over how α-SYN behaves in the cell: is it an intrinsically disordered protein or a stable tetramer with a low propensity for aggregation? In this review, we discuss the aggregation of α-SYN and describe factors that influence this process and their potential relevance in PD pathogenesis. We address the ways in which aggregated α-SYN mediates toxicity and might lead to PD, and propose possible therapeutic strategies.
Copyright © 2013 Elsevier Ltd. All rights reserved.
Similar articles
-
α-Synuclein misfolding and aggregation: Implications in Parkinson's disease pathogenesis.Biochim Biophys Acta Proteins Proteom. 2019 Oct;1867(10):890-908. doi: 10.1016/j.bbapap.2019.03.001. Epub 2019 Mar 7. Biochim Biophys Acta Proteins Proteom. 2019. PMID: 30853581 Review.
-
α-Synuclein Misfolding Versus Aggregation Relevance to Parkinson's Disease: Critical Assessment and Modeling.Mol Neurobiol. 2015;51(3):1417-31. doi: 10.1007/s12035-014-8818-2. Epub 2014 Aug 20. Mol Neurobiol. 2015. PMID: 25139280 Review.
-
The Parkinson's disease-associated H50Q mutation accelerates α-Synuclein aggregation in vitro.Biochemistry. 2013 Oct 8;52(40):6925-7. doi: 10.1021/bi400999d. Epub 2013 Sep 23. Biochemistry. 2013. PMID: 24047453
-
The aggregation and fibrillation of alpha-synuclein.Acc Chem Res. 2006 Sep;39(9):628-34. doi: 10.1021/ar050073t. Acc Chem Res. 2006. PMID: 16981679 Review.
-
Alteration of Structure and Aggregation of α-Synuclein by Familial Parkinson's Disease Associated Mutations.Curr Protein Pept Sci. 2017;18(7):656-676. doi: 10.2174/1389203717666160314151706. Curr Protein Pept Sci. 2017. PMID: 26972727 Review.
Cited by
-
Aptamer and its applications in neurodegenerative diseases.Cell Mol Life Sci. 2017 Feb;74(4):683-695. doi: 10.1007/s00018-016-2345-4. Epub 2016 Aug 25. Cell Mol Life Sci. 2017. PMID: 27563707 Free PMC article. Review.
-
Structural and dynamical insights into the membrane-bound α-synuclein.PLoS One. 2013 Dec 20;8(12):e83752. doi: 10.1371/journal.pone.0083752. eCollection 2013. PLoS One. 2013. PMID: 24376740 Free PMC article.
-
Control of protein orientation on gold nanoparticles.J Phys Chem C Nanomater Interfaces. 2015 Sep 10;119(36):21035-21043. doi: 10.1021/acs.jpcc.5b07701. Epub 2015 Aug 18. J Phys Chem C Nanomater Interfaces. 2015. PMID: 28626495 Free PMC article.
-
The Role of α-Synuclein in the Regulation of Serotonin System: Physiological and Pathological Features.Biomedicines. 2023 Feb 13;11(2):541. doi: 10.3390/biomedicines11020541. Biomedicines. 2023. PMID: 36831077 Free PMC article. Review.
-
Ceftriaxone blocks the polymerization of α-synuclein and exerts neuroprotective effects in vitro.ACS Chem Neurosci. 2014 Jan 15;5(1):30-8. doi: 10.1021/cn400149k. Epub 2013 Oct 24. ACS Chem Neurosci. 2014. PMID: 24099687 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous